THE EVALUATION OF CLINICAL AND LABORATORY FINDINGS OF THE PATIENTS ON CAPD TREATMENT BETWEEN 1996-2000

evaluated in the light of their clinical status, laboratory data and the adequacy and the complications of dialysis who were on continuous ambulatory peritoneal dialysis (CAPD) treatment between September 1996 and October 2000. Thirteen female and 15 male patients were followed up 21±12,39 months in avarage and their mean age was 48,96^15,96 years. rHuEpo treatment was required by 18 patients with anemia and the anemia seen in the rest of the patients became normal, without rHuEpo treatment. Blood pressure control of our patients become easy by CAPD, furthermore, the antihypertensive . treatment were discontinued in some patients. Hypoalbuminemia, as a common complication of CAPD treatment, was not developed in our patients. Hyperlipidemia was seen as an important outcome, whereas renal osteodystrophy and neuropathy did not seem to cause any problem during this period. The adequacy parameters of peritoneal dialysis were achieved in our patients. Peritonitis was still the most serious problem, the rate of peritonitis was 1 / 10,5 patientmonths. The most common responsible agent was Staphylococcus aureus (% 19,64). As a result, two patients passed away, one of them had sudden death and the other one had septicemia after peritonitis. Four patients were converted to HD treatment. The encountered problems for each patient were as follows: relapsing peritonitis, tunnel infection with peritonitis, fungal peritonitis and outflow failure. One of our CAPD patients received renal transplantation. The rest of the patients were continued on peritoneal dialysis. Although CAPD treatment has a lot of advantages as a renal replacement therapy in patients with end stage renal failure, peritonitis still remains as a serious complication in our country.